An experimental vaccine showed promise in treating aggressive breast cancer, while a new gene therapy method advances ...
Harvard Medical School researchers have taken another decisive step in their efforts to develop a gene therapy for people ...
The San Diego biotech made an unsolicited bid to buy Evotec for 2 billion euros. Elsewhere, Bluebird recorded its first ...
Computer scientists, bioengineers and AI specialists from the Arc Institute and Stanford University have developed an ...
Harvard Medical School researchers have taken another decisive step in their efforts to develop a gene therapy for people ...
AZoLifeSciences on MSN8h
AI Tool Predicts Gene Activity from Tumor Images to Guide TreatmentTo determine the type and severity of a cancer, pathologists typically analyze thin slices of a tumor biopsy under a ...
Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis ...
In a phase 2 trial, a gene therapy reduced angioedema attacks, which could significantly change the quality of life for ...
These three emerging technology leaders are pioneering quantum computing, gene editing, and electric aviation.
A Seattle biotech company is working on a tweak to gene expression that could shut down hepatitis B (HBV), one of the viruses ...
It has been years since I have considered restarting a position in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) after having ...
Neurogene reports interim Phase 1/2 trial results for NGN-401 gene therapy in treating pediatric Rett syndrome, showing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback